drugset / Trial / NCT02084797

V2 Receptor Effects on Fluid Regulation and Performance

NCT02084797

RandomizedCrossoverDouble-blind

Summary

This primary aim of this study was to critically assess whether or not sweat water content and sodium concentration were acutely regulated by dynamic changes in antidiuretic hormone (arginine vasopressin or AVP) acting on the Vasopressin 2 receptor (V2R) during exercise. Secondary aims were to evaluate running performance and core temperature to further characterize the role of AVP in the coordinated balance of fluid and temperature homeostasis during exercise. The primary hypothesis was that activation of the V2R in sweat glands would result in water reabsorption and fluid conservation during endurance exercise.

Timeline

Start
2011-06
Primary completion
2011-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmopressin Peptide 0.2 mg Oral
Subject Tolvaptan Small molecule 30 mg Oral

Indications

No indication recorded.